Regojo-Balboa, J.M. (J. M.)

Filtering

2002 - 20054

Settings

Author search.filters.isAuthorOfPublication.7a37136e-eaf4-4e65-853d-a720d8881d67

Search Results

Now showing 1 - 4 of 4
  • Thumbnail Image
    Litiasis renal secundaria a Indinavir
    (Ediciones Universidad de Navarra, 2002) Rosell, D. (David); Fernandez-Montero, J.M. (J. M.); Lopez, J. (J.); Zudaire-Bergera, J.J. (Juan Javier); Arocena, J. (J.); Sánchez, D. (D.); Regojo-Balboa, J.M. (J. M.); Berian-Polo, J.M. (José María); Robles-Garcia, J.E. (José Enrique)
    Indinavir sulphate is a protease inhibitor that has been found to be extremely effective in increasing CD4+ cell counts and in decreasing HIV-RNA titers in patients with HIV and AIDS. However, patients receiving indinavir also have been noted to have a significant risk of developing urolithiasis. Indinavir has high urinary excretion with poor solubility in a physiologic pH solution. The typical symptoms of indinavir urolithiasis are similar to other forms of urolithiasis. Indinavir urolithiasis is unique in that computed tomography, which was once thought to be efficacious in identifying all urinary calculi, is not useful in imaging stones that are composed of pure indinavir. Indinavir urolithiasis generally responds to a conservative regimen of hydration, pain control, and temporary discontinuation of the medication. Only a minority of patients need surgical intervention.
  • Thumbnail Image
    Litiasis renal secundaria a Indinavir
    (Servicio de Publicaciones de la Universidad de Navarra, 2002) Rosell, D. (David); Lopez, J. (J.); Zudaire-Bergera, J.J. (Juan Javier); Arocena, J. (J.); Sánchez, D. (D.); Regojo-Balboa, J.M. (J. M.); Berian-Polo, J.M. (José María); Fernández-Gómez, J.M.(Jesús M.); Robles-Garcia, J.E. (José Enrique)
    Indinavir sulphate is a protease inhibitor that has been found to be extremely effective in increasing CD4+ cell counts and in decreasing HIV-RNA titers in patients with HIV and AIDS. However, patients receiving indinavir also have been noted to have a significant risk of developing urolithiasis. Indinavir has high urinary excretion with poor solubility in a physiologic pH solution. The typical symptoms of indinavir urolithiasis are similar to other forms of urolithiasis. Indinavir urolithiasis is unique in that computed tomography, which was once thought to be efficacious in identifying all urinary calculi, is not useful in imaging stones that are composed of pure indinavir. Indinavir urolithiasis generally responds to a conservative regimen of hydration, pain control, and temporary discontinuation of the medication. Only a minority of patients need surgical intervention.
  • Thumbnail Image
    Tratamiento quirúrgico de la incontinencia: TVT
    (Ediciones Universidad de Navarra, 2005) Rosell, D. (David); Fernandez-Montero, J.M. (J. M.); Zudaire-Bergera, J.J. (Juan Javier); Regojo-Balboa, J.M. (J. M.); Saiz-Sansi, A. (Abel); Lopez-Ferrandiz, J. (J.); Rioja-Zuazu, J. (Jorge); Berian-Polo, J.M. (José María); Robles-Garcia, J.E. (José Enrique)
    The T.V.T. procedure has become a technique for Urinary incontinence and its different presentations. Many trials have reported the efficacy of this technique for different situations, as well as its results and complications. We review the literature and analyze the results and complications, comparing this technique with other such procedures
  • Thumbnail Image
    Incontinencia femenina: evaluación urodinámica
    (Ediciones Universidad de Navarra, 2004) Rosell, D. (David); Fernandez-Montero, J.M. (J. M.); Zudaire-Bergera, J.J. (Juan Javier); Regojo-Balboa, J.M. (J. M.); Lopez-Ferrandiz, J. (J.); Rioja-Zuazu, J. (Jorge); Berian-Polo, J.M. (José María); Sainz-Sansi, A. (Abel); Robles-Garcia, J.E. (José Enrique)
    Although prospective randomized controlled trials to evaluate the clinical efficacy, cost-effectiveness and effect on quality of life of a pre-operative Urodynamic assessment are necessary, to date only Urodynamic Investigation (Non-invasive uroflowmetry, filling cystometrogram, valsalva leak point pressure, pressure-flow studies and urethral profile) provide enough information for treatment decisions and prognosis in cases of female urinary incontinenc